The structure of the MAP2K MEK6 reveals an autoinhibitory dimer.

MAP2Ks are dual-specificity protein kinases functioning at the center of three-tiered MAP kinase modules. The structure of the kinase domain of the MAP2K MEK6 with phosphorylation site mimetic aspartic acid mutations (MEK6/DeltaN/DD) has been solved at 2.3 angstroms resolution. The structure reveals an autoinhibited elongated ellipsoidal dimer. The enzyme adopts an inactive conformation, based upon structural queues, despite the phosphomimetic mutations. Gel filtration and small-angle X-ray scattering analysis confirm that the crystallographically observed ellipsoidal dimer is a feature of MEK6/DeltaN/DD and full-length unphosphorylated wild-type MEK6 in solution. The interface includes the phosphate binding ribbon of each subunit, part of the activation loop, and a rare "arginine stack" between symmetry-related arginine residues in the N-terminal lobe. The autoinhibited structure likely confers specificity on active MAP2Ks. The dimer may also serve the function in unphosphorylated MEK6 of preventing activation loop phosphorylation by inappropriate kinases.

[1]  Bai-Lin Wu,et al.  High Intensity ras Signaling Induces Premature Senescence by Activating p38 Pathway in Primary Human Fibroblasts* , 2004, Journal of Biological Chemistry.

[2]  J. Zheng,et al.  Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. , 1991, Science.

[3]  F. Ashcroft,et al.  A Novel Method for Measurement of Submembrane ATP Concentration* , 2000, The Journal of Biological Chemistry.

[4]  L. Bardwell,et al.  Mechanisms of MAPK signalling specificity. , 2006, Biochemical Society transactions.

[5]  D. Kessler,et al.  Biochemical and biological analysis of Mek1 phosphorylation site mutants. , 1995, Molecular biology of the cell.

[6]  Ricardo M Biondi,et al.  Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions. , 2003, The Biochemical journal.

[7]  C. Carter,et al.  Overcoming non-isomorphism by phase permutation and likelihood scoring: solution of the TrpRS crystal structure. , 1994, Acta crystallographica. Section A, Foundations of crystallography.

[8]  Elizabeth J. Goldsmith,et al.  Activation Mechanism of the MAP Kinase ERK2 by Dual Phosphorylation , 1997, Cell.

[9]  Elizabeth J. Goldsmith,et al.  Substrate and Docking Interactions in Serine/Threonine Protein Kinases , 2008 .

[10]  H. Saito,et al.  Conserved docking site is essential for activation of mammalian MAP kinase kinases by specific MAP kinase kinase kinases. , 2005, Molecular cell.

[11]  J. Sebolt-Leopold,et al.  Mechanisms of drug inhibition of signalling molecules , 2006, Nature.

[12]  M. Cobb,et al.  MAP kinases. , 2001, Chemical reviews.

[13]  Lee Bardwell,et al.  Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity. , 2003, The Biochemical journal.

[14]  E. Racker.  Use of synthetic amino acid polymers for assay of protein-tyrosine and protein-serine kinases. , 1991, Methods in enzymology.

[15]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[16]  E. Goldsmith,et al.  Crystal structure of the TAO2 kinase domain: activation and specificity of a Ste20p MAP3K. , 2004, Structure.

[17]  John A Tainer,et al.  Structural analysis of flexible proteins in solution by small angle X-ray scattering combined with crystallography. , 2006, Journal of structural biology.

[18]  R. Seger,et al.  The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions , 2006, Growth factors.

[19]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[20]  H. Scheraga,et al.  Contribution of unusual Arginine-Arginine short-range interactions to stabilization and recognition in proteins , 1994, Journal of protein chemistry.

[21]  Jiahuai Han,et al.  Characterization of the Structure and Function of a Novel MAP Kinase Kinase (MKK6) (*) , 1996, The Journal of Biological Chemistry.

[22]  A. Doweyko,et al.  Structural comparison of p38 inhibitor-protein complexes: a review of recent p38 inhibitors having unique binding interactions. , 2005, Current topics in medicinal chemistry.

[23]  Wange Lu,et al.  Structure of PAK1 in an Autoinhibited Conformation Reveals a Multistage Activation Switch , 2000, Cell.

[24]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[25]  R B Sutton,et al.  Structure of human synaptotagmin 1 C2AB in the absence of Ca2+ reveals a novel domain association. , 2007, Biochemistry.

[26]  H. Enslen,et al.  Molecular determinants that mediate selective activation of p38 MAP kinase isoforms , 2000, The EMBO journal.

[27]  Arvin C. Dar,et al.  Mechanistic Link between PKR Dimerization, Autophosphorylation, and eIF2α Substrate Recognition , 2005, Cell.

[28]  John Kuriyan,et al.  An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor Receptor , 2006, Cell.

[29]  Sam-Yong Park,et al.  Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125 , 2004, The EMBO journal.

[30]  P. Caron,et al.  Crystal structure of JNK3: a kinase implicated in neuronal apoptosis. , 1998, Structure.

[31]  J. Kuriyan,et al.  The Conformational Plasticity of Protein Kinases , 2002, Cell.

[32]  C. Tournier,et al.  Regulation of cellular functions by the ERK5 signalling pathway. , 2006, Cellular signalling.

[33]  Bo Zhou,et al.  Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Jiahuai Han,et al.  Activation and signaling of the p38 MAP kinase pathway , 2005, Cell Research.

[35]  E. Nishida,et al.  Molecular recognitions in the MAP kinase cascades. , 2003, Cellular signalling.

[36]  A. Manning,et al.  Targeting JNK for therapeutic benefit: from junk to gold? , 2003, Nature Reviews Drug Discovery.

[37]  Elizabeth J. Goldsmith,et al.  Atomic structure of the MAP kinase ERK2 at 2.3 Å resolution , 1994, Nature.

[38]  Anastassis Perrakis,et al.  Automated protein model building combined with iterative structure refinement , 1999, Nature Structural Biology.

[39]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[40]  George M Sheldrick,et al.  Substructure solution with SHELXD. , 2002, Acta crystallographica. Section D, Biological crystallography.

[41]  Wei Chen,et al.  Differential regulation and properties of MAPKs , 2007, Oncogene.

[42]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[43]  M. Marjanovic,et al.  A comparison of effect of temperature on phosphorus metabolites, pH and Mg2+ in human and ground squirrel red cells. , 1993, The Journal of physiology.

[44]  S. Hubbard.  Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog , 1997, The EMBO journal.

[45]  A. Wittinghofer,et al.  The 2.2 Å crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with RaplA and a GTP analogue , 1995, Nature.

[46]  D I Svergun,et al.  Determination of domain structure of proteins from X-ray solution scattering. , 2001, Biophysical journal.

[47]  Wendell A Lim,et al.  The role of docking interactions in mediating signaling input, output, and discrimination in the yeast MAPK network. , 2005, Molecular cell.

[48]  Greg L. Hura,et al.  X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution. , 2011, Quarterly reviews of biophysics.

[49]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[50]  K. Wilson,et al.  The structure of phosphorylated p38gamma is monomeric and reveals a conserved activation-loop conformation. , 1999, Structure.

[51]  E. Goldsmith,et al.  The structure of mitogen-activated protein kinase p38 at 2.1-A resolution. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[52]  T. Haystead,et al.  Ordered phosphorylation of p42mapk by MAP kinase kinase , 1992, FEBS letters.

[53]  M. Cobb,et al.  Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. , 2001, Endocrine reviews.

[54]  Radha Akella,et al.  Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b. , 2002, Molecular cell.

[55]  G. Johnson,et al.  Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases , 2002, Science.

[56]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[57]  G. Rose,et al.  Loops in globular proteins: a novel category of secondary structure. , 1986, Science.

[58]  D. Svergun,et al.  Small-angle scattering: a view on the properties, structures and structural changes of biological macromolecules in solution , 2003, Quarterly Reviews of Biophysics.

[59]  Jay Painter,et al.  Electronic Reprint Biological Crystallography Optimal Description of a Protein Structure in Terms of Multiple Groups Undergoing Tls Motion Biological Crystallography Optimal Description of a Protein Structure in Terms of Multiple Groups Undergoing Tls Motion , 2005 .

[60]  D. Barford,et al.  Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF , 2004, Cell.

[61]  E. Racker,et al.  Synthetic tyrosine polymers as substrates and inhibitors of tyrosine-specific protein kinases. , 1984, The Journal of biological chemistry.

[62]  Z. Derewenda,et al.  Overcoming expression and purification problems of RhoGDI using a family of "parallel" expression vectors. , 1999, Protein Expression and Purification.

[63]  E. Goldsmith,et al.  Docking interactions induce exposure of activation loop in the MAP kinase ERK2. , 2006, Structure.

[64]  J. Warmus,et al.  Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition , 2004, Nature Structural &Molecular Biology.